Related Experiment Videos
Platelet-activating factor is a mediator in tumor necrosis factor/galactosamine-induced lethality
C Libert1, W Van Molle, P Brouckaert
1Laboratory of Molecular Biology, University of Ghent, Belgium.
Abstract:
We here report that administration to mice of WEB2170, a potent platelet-activating factor (PAF) receptor antagonist, prevents both PAF-induced and murine tumor necrosis factor (TNF)-induced lethality in galactosamine (GalN)-sensitized mice. Furthermore, we demonstrate that pretreatment with alpha 1-acid glycoprotein (AGP) or interleukin-1 (IL-1) protects against TNF-induced, but not against PAF-induced lethality. We conclude that PAF is a mediator in TNF/GalN-induced lethal shock, but that the protection conferred by AGP or IL-1 pretreatment is not at the level of scavenging PAF.
Insights
Platelet-activating factor (PAF) mediates lethal shock induced by tumor necrosis factor (TNF) and galactosamine (GalN). However, alpha 1-acid glycoprotein (AGP) or interleukin-1 (IL-1) protection against TNF/GalN lethality does not involve scavenging PAF.
Area of Science:
- Pharmacology
- Immunology
- Toxicology
Background:
- Tumor necrosis factor (TNF) can induce lethal shock in galactosamine (GalN)-sensitized hosts.
- Platelet-activating factor (PAF) is implicated in various inflammatory and shock conditions.
- Understanding the mediators of lethal shock is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of PAF in TNF/GalN-induced lethal shock.
- To determine if PAF receptor antagonists can prevent this lethal outcome.
- To elucidate the mechanism of protection offered by alpha 1-acid glycoprotein (AGP) and interleukin-1 (IL-1) in this model.
Main Methods:
- Administration of WEB2170, a PAF receptor antagonist, to GalN-sensitized mice challenged with PAF or TNF.
- Pretreatment of GalN-sensitized mice with AGP or IL-1 before TNF or PAF challenge.
- Assessment of survival rates to determine lethality.
Main Results:
- WEB2170 significantly prevented lethality induced by both PAF and TNF in GalN-sensitized mice.
- AGP and IL-1 pretreatment protected mice against TNF-induced lethality but not against PAF-induced lethality.
- These findings indicate that PAF is a key mediator in the TNF/GalN lethal shock pathway.
Conclusions:
- PAF is a critical mediator in TNF/GalN-induced lethal shock.
- The protective effects of AGP and IL-1 against TNF/GalN lethality are not mediated by direct PAF scavenging.
- Further research is needed to understand the precise mechanisms of AGP and IL-1 in modulating lethal shock pathways.